|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-05
|
$347,563
|
$347,563
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$91,803
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$5,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$2,725
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$1,514
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$635
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Understanding how patient-derived resistance mutations affect the process of imatinib binding to Abl kinase
|
1F30CA225172-01A1
|
$32,574
|
$32,574
|
LYCZEK, AGATHA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Transcription and Splicing Dynamics in Single Cells
|
ZIA BC 011383
|
$964,491
|
$96,449
|
Larson, Daniel
|
CCR (NCI)
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
3P30CA196521-04S1
|
$249,999
|
$35,000
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
3P30CA196521-04S2
|
$224,981
|
$31,497
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
5P30CA196521-04
|
$2,373,000
|
$332,220
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia
|
5R00CA181488-05
|
$249,000
|
$249,000
|
LOSMAN, JULIE
|
DANA-FARBER CANCER INST
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-24
|
$6,420,169
|
$128,403
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S1
|
$250,000
|
$5,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S2
|
$200,000
|
$4,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S3
|
$246,169
|
$4,923
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S4
|
$58,383
|
$1,168
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Targeting PML for Leukemia Therapy
|
5R01CA142874-08
|
$457,619
|
$457,619
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$366,567
|
$91,642
|
Tosato, Giovanna
|
CCR (NCI)
|
|
STUDIES OF BCR-ABL LEUKEMOGENESIS IN MICE
|
5R01CA090576-18
|
$293,550
|
$293,550
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-05
|
$620,114
|
$620,114
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
SPORE in Myeloid Malignancies
|
5P50CA206963-02
|
$2,300,000
|
$276,000
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Sphingolipids in Cancer Biology and Therapy
|
5P01CA097132-15
|
$1,298,387
|
$181,774
|
HANNUN, YUSUF
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$679,649
|
$271,860
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Specialized Program Of Research Excellence (SPORE) in Leukemia.
|
2P50CA171963-06
|
$2,299,839
|
$390,973
|
LINK, DANIEL
|
WASHINGTON UNIVERSITY
|
|
Specialized Program Of Research Excellence (SPORE) in Leukemia.
|
3P50CA171963-06S1
|
$66,323
|
$11,275
|
LINK, DANIEL
|
WASHINGTON UNIVERSITY
|
|
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
|
5U54CA193419-04
|
$2,095,133
|
$963,761
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Role of autophagy in normal and transformed hematopoietic stem cells
|
5R01CA184014-05
|
$332,000
|
$332,000
|
PASSEGUE, EMMANUELLE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
|
5K22CA190674-04
|
$161,692
|
$80,846
|
BARTH, BRIAN
|
UNIVERSITY OF NEW HAMPSHIRE
|
|
Predictors of Myelodysplastic Syndrome in Minnesota
|
2R01CA142714-06A1
|
$600,172
|
$600,172
|
POYNTER, JENNY
|
UNIVERSITY OF MINNESOTA
|
|
Pathogenic Mechanisms of CSF3R Mutations in Leukemia
|
5R00CA190605-05
|
$239,586
|
$239,586
|
MAXSON, JULIA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
|
5R01CA183974-05
|
$319,550
|
$319,550
|
TYNER, JEFFREY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-20S1
|
$225,000
|
$9,000
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-20S2
|
$248,465
|
$9,939
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-20S3
|
$124,966
|
$4,999
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
5P30CA069533-20
|
$2,310,000
|
$92,400
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies
|
1R01CA232845-01
|
$630,136
|
$630,136
|
IZUMIYA, YOSHIHIRO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
MPN Research Consortium
|
2P01CA108671-10A1
|
$3,937,342
|
$3,701,101
|
HOFFMAN, RONALD
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Molecular-Cellular Regulation of Hematopoietic Stem Cells
|
ZIA BC 010001
|
$776,575
|
$194,144
|
Keller, Jonathan
|
CCR (NCI)
|
|
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
|
5R01CA152108-07
|
$373,634
|
$373,634
|
ZHANG, JING
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-20S1
|
$60,000
|
$600
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-20S2
|
$86,294
|
$863
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-20S3
|
$185,151
|
$1,852
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-20S4
|
$75,701
|
$757
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
5P30CA076292-20
|
$2,990,966
|
$29,910
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Modeling Splicing Factor Mutations in MDS Using Human iPSCs
|
1F31CA228295-01
|
$44,364
|
$44,364
|
VORA, SHAILEE
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Mechanistic Dissection of the Falconi Anemia Pathway of DNA Damage Response and Repair
|
5R01CA168635-06
|
$394,130
|
$394,130
|
SUNG, PATRICK
|
YALE UNIVERSITY
|
|
Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia
|
5R01CA178397-05
|
$483,771
|
$483,771
|
O'HARE, THOMAS
|
UNIVERSITY OF UTAH
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
5R01CA101774-16
|
$337,725
|
$337,725
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Mechanism of non-oncogene addiction
|
1R01CA211594-01A1
|
$363,713
|
$363,713
|
AZAM, MOHAMMAD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $19,494,791
|